6 results
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Tranexamic Acid ... Pharmacology Pharmacokinetics ... TXA #Tranexamic #Acid ... #Indications #Pharmacology ... #hematology
Drug Induced Systemic Lupus Erythematosus
> 100 drugs have been associated with drug-induced SLE
High risk (>5%):
 •
for 1 year of treatment ... Lisinopril, Nalidixic acid ... Erythematosus #medications ... #drugs #pharmacology ... differential #diagnosis #rheumatology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Bumetanide, Ethacrynic acid ... Torsemide) • Acute pulmonary ... Kidney stones caused ... Tolvaptan) • Treatment ... #Medications #Table
A quick infographic on various pearls about atopic dermatitis, a disease with an increasing burden on
recommendations, treatments ... #management #medications ... #causes #atopy ... J Am Acad Dermatol ... Role of the Gut
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
group of disorders caused ... anemia DDX: Rule Out ... Secondary Causes ... vitamin B12 or folic acid ... Syndromes #diagnosis #hematology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Hypocomplementemia • Can cause ... Nephrogenic DI Hematologic ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Sjogrens #Syndrome #Rheumatology